@article{TLCR19489,
author = {Antonio Passaro and Filippo de Marinis},
title = {Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {The identification of EGFR mutations in non-small cell lung cancer (NSCLC) changed deeply the treatment of this disease harbouring these kind of DNA alterations, that occur respectively in about 10–15% and 45–50% of Caucasian and Asian patients (1,2).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/19489}
}